Fox Run Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$203K Buy
+41,354
New +$243K 0.02% 857
2026
Q1
– Sell
-28,571
Closed -$298K – 1193
2025
Q4
$298K Sell
28,571
-702
-2% -$7.04K 0.05% 701
2025
Q3
$263K Buy
+29,273
New +$257K 0.04% 728
2025
Q2
– Sell
-10,161
Closed -$257K – 1178
2025
Q1
$257K Sell
10,161
-19,297
-66% -$573K 0.04% 722
2024
Q4
$1.01M Buy
29,458
+9,443
+47% +$426K 0.18% 152
2024
Q3
$989K Buy
+20,015
New +$1.03M 0.22% 128
2024
Q2
– Sell
-11,346
Closed -$585K – 1032
2024
Q1
$585K Sell
11,346
-532
-4% -$26.1K 0.13% 309
2023
Q4
$479K Buy
+11,878
New +$348K 0.12% 320

Other funds holding RXST

Fox Run Management's RXST Position: Q3 2026 in Review

Fox Run Management opened a new position in RxSight (RXST) in Q3 2026: 41,354 shares worth $203K. The stake represents 0.02% of the portfolio and ranks #857 among its holdings. This is a return to the name: Fox Run Management previously reported a position in RXST as recently as Q4 2025.

Fox Run Management first reported a position in RXST in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.01M in Q4 2024. 97 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Fox Run Management held 41,354 shares of RxSight worth $203K as of Q3 2026.
  • RxSight was a new Fox Run Management position in Q3 2026.
  • RxSight made up 0.02% of Fox Run Management's portfolio in Q3 2026, its #857 holding.
  • Fox Run Management first reported a position in RxSight in Q4 2023 and has held it in 8 quarters since.
  • Fox Run Management's RxSight position peaked at $1.01M in Q4 2024.
  • 97 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.